Clinical TrialMajor Depressive Disorder (MDD)KetamineCompleted

Ketamine IV Classic Protocol : Five Years Follow up

Patients who suffer from MDD received ketamine (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Target Enrollment
11 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

Retrospective five-year follow-up of outpatients with Major Depressive Disorder who previously received IV ketamine in 2014–15; clinical state reassessed using the same rating scales as the original study.

Assessments include time to relapse, current medications, and drug-use history; sample consists of 11 actual participants from the original protocol (study 1126).

Study Arms & Interventions

Observational follow-up

experimental

Five-year follow-up of patients who received ketamine in 2014–15

Interventions

  • Ketamine

    Retrospective observational follow-up; no study dosing. Participants previously received IV ketamine in 2014–15.

Participants

Ages
18 – 80
Sexes
Male & Female

Inclusion Criteria

  • Patient who participated in ketamine study 1126 and are willing to participate

Exclusion Criteria

  • None

Study Details

Locations

The Chaim Sheba Medical Center — Tel Litwinsky, Israel

Your Library